November 22-23, 2010
William H. Natcher Conference Center, National Institutes of Health, Bethesda, MD 20892
Reproductive Sciences (RS) Branch, Center for Population Research (CPR), Reproductive Biology and Medicine Branch (RBMB), Division of Intramural Research (DIR), NICHD, NIH; National Institute of Environmental Health Sciences, NIH; Office of Research on Women’s Health, NIH; National Cancer Institute, NIH; National Center for Research Resources, NIH; National Institute of Biomedical Imaging and Bioengineering, NIH; National Institute of Nursing Research, NIH; Office of Women’s Health, Office of the Secretary, U.S. Department of Health and Human Services; Agency for Healthcare Research and Quality; Centers for Disease Control and Prevention; Food and Drug Administration; Health Resources & Services Administration
Uterine leiomyomas (fibroids) are the most common gynecologic neoplasms in women of reproductive age. As the number one cause of hysterectomy, they have a profoundly negative impact on women’s health. Uterine leiomyomas are hormonally dependent and as such are a potential target for endocrine active compounds in the environment.
The goal of this conference is to bring together researchers working in the fields of medicine, epidemiology, basic research, and therapeutics to foster an exchange of scientific information among members of the uterine leiomyoma research community. Participants will be drawn from academia, medicine, government, and industry.
Topics to be covered include Clinical Management and Therapeutic Strategies, Epidemiology, Pathogenesis, Environmental Influences, Model Systems, Hormonal Regulation, and Molecular and (Epi)Genetic Characteristics.
Estella Parrott, M.D., M.P.H., RSB, CPR, NICHDPhone: 301-496-6515E-mail: firstname.lastname@example.org
James Segars, M.D., RBMB, NICHDPhone: 301-496-5800E-mail: email@example.com
All related topics